TribLIVE

| Business


 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

Bayer AG earnings up 7.7% during 3Q

On the Grid

From the shale fields to the cooling towers, Trib Total Media covers the energy industry in Western Pennsylvania and beyond. For the latest news and views on gas, coal, electricity and more, check out On the Grid today.

By Staff and Wire Reports
Thursday, Oct. 31, 2013, 11:03 a.m.
 

Bayer AG's third-quarter earnings rose 7.7 percent on higher sales for a new blood thinner and eye treatment that are recharging its drug portfolio.

Operating profit rose to $2.7 billion from $2.5 billion a year earlier, the Leverkusen, Germany-based parent of Bayer Corp. in Robinson said on Thursday. That beat the $2.55 billion average estimate of 11 analysts surveyed by Bloomberg.

New medicines, including the blood thinner Xarelto and the eye drug Eylea, have helped drive Bayer's profit upward even as earnings from its MaterialScience plastics division lag. Bayer is in talks with workers to cut costs at the unit, which makes chemicals for everything from makeup to car parts, CEO Marijn Dekkers told reporters in September.

“People do want to own this for the pharma growth,” said Fabian Wenner, an analyst for Kepler Cheuvreux in Zurich. “Investors don't really care about 2013 anymore.” Wenner rates the stock a hold.

Third-quarter sales fell 0.2 percent to $13.1 billion, below the average analyst estimate of $13.3 billion.

Bayer Corp.'s operations in North America had $2.83 billion in sales, down 3.6 percent from a year ago. For the first nine months of the year, sales were $9.94 billion, up 1.4 percent compared to the same period in 2012. Bayer has 15,400 employees in North America, including 2,300 in the Pittsburgh region, the largest of 50 Bayer sites in the United States.

Bloomberg News and Trib Total Media staff writer John D. Oravecz contributed to this report. He can be reached at 412-320-7882 or joravecz@tribweb.com.

 

 
 


Show commenting policy

Most-Read Business Headlines

  1. Bayer profit edges higher, raises forecasts
  2. Hedge funds sue to block EDMC deal
  3. Kennametal profit, sales improve in 1Q, but forecast reduced
  4. Highmark’s new REMWorks Sleep Store will sell sleep apnea equipment
  5. Profit falls at vitamin retailer GNC Holdings in third quarter
  6. Apple CEO Tim Cook: ‘I’m proud to be gay’
  7. CCAC, Energy Innovation Center respond to energy industry’s growing demand
  8. Roundup: WesBanco to acquire ESB Financial for $324M; PNC to replace credit cards used during Home Depot breach; more
  9. Range Resources reports $146M in Q3 profits on record Marcellus production
  10. Underestimated income to cost insured workers
  11. Investors jockey for higher rates as Fed sounds note of optimism on economy
Subscribe today! Click here for our subscription offers.